Best Biotech Stocks

Gilead (GILD), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) are some of the most trending stocks in the biotech sector. See how they compare to other companies such as Biogen (BIIB), Illumina (ILMN) and Regeneron (REGN).

Compare up to 10 stocks

RESET ALL

GILD AMGN VRTX BIIB ILMN REGN MRNA IQV BNTX

Comparison Results

Name	Price	Volume	Analyst Price Target	Analyst Consensus	Market Cap	P/E Ratio	Dividend Yield	Sector
GILD Gilead Sciences	$90.19	4.55M	xxxxxxxxxxxxx	14 Buy 10 Hold 0 Sell Moderate Buy	$111.86B	1.01K	3.45%	Healthcare
AMGN Amgen	$294.53	3.05M	xxxxxxxxxxxxx	11 Buy 11 Hold 1 Sell Moderate Buy	$155.83B	37.12	3.08%	Healthcare
VRTX Vertex Pharmaceuticals	$450.97	1.27M	xxxxxxxxxxxxx	16 Buy 9 Hold 2 Sell Moderate Buy	$115.98B	-225.95	―	Healthcare
BIIB Biogen	$157.90	1.70M	xxxxxxxxxxxxx	14 Buy 11 Hold 0 Sell Moderate Buy	$23.03B	14.27	―	Healthcare
ILMN Illumina	$140.14	2.05M	xxxxxxxxxxxxx	10 Buy 6 Hold 1 Sell Moderate Buy	$21.73B	-13.70	―	Healthcare
REGN Regeneron	$738.00	1.03M	xxxxxxxxxxxxx	17 Buy 5 Hold 1 Sell Moderate Buy	$81.81B	18.42	―	Healthcare
MRNA Moderna	$41.11	13.41M	xxxxxxxxxxxxx	6 Buy 11 Hold 3 Sell Hold	$14.72B	-6.57	―	Healthcare
IQV IQVIA Holdings	$201.82	1.89M	xxxxxxxxxxxxx	16 Buy 2 Hold 0 Sell Strong Buy	$35.86B	25.92	―	Healthcare
BNTX BioNTech SE	$113.13	1.19M	xxxxxxxxxxxxx	12 Buy 4 Hold 0 Sell Strong Buy	$25.95B	-51.52	―	Healthcare

Performance Comparison

GILD

Gilead Sciences

90.19

17.82

24.62%

AMGN

Amgen

294.53

36.86

14.31%

VRTX

Vertex Pharmaceuticals

450.37

97.33

27.57%

BIIB

Biogen

158.01

-73.94

-31.88%

ILMN

Illumina

136.99

41.42

43.34%

REGN

Regeneron

738.00

-60.30

-7.55%

MRNA

Moderna

38.25

-40.27

-51.29%

IQV

IQVIA Holdings

197.60

-14.41

-6.80%

BNTX

BioNTech SE

113.13

14.30

14.47%

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Biotech Stocks Latest News

FDA posts observations from previous Regeneron facility inspection

The FDA posted a summary of observations made from the Agency’s inspection of a Regeneron (REGN) facility in...

14h ago

REGN

Moderna up as Jefferies suggests ‘peak RFK negativity’ may have been reached

Jefferies hosted a fireside meeting with Moderna (MRNA) management, where the company noted that COVID vaccines are currently...

14h ago

MRNA

Trump Trade: Trump Media considers developing crypto payment service

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...

15h ago

BXP

CUZ

Early notable gainers among liquid option names on November 22nd

Notable gainers among liquid option names this morning include Super Micro (SMCI) $34.08 +4.38, Copart (CPRT) $61.52 +4.62,...

16h ago

TPR

CPRT

Trump expected to pick Martin Makary to head FDA, Reuters reports

Johns Hopkins surgeon and writer Martin Makary is expected to be selected by President-elect Donald Trump to head...

16h ago

GSK

PFE

SPY ETF Update, 11/22/2024

How is SPY stock faring? The SPDR S&P 500 ETF Trust is up 1.39% in the past five days and...

20h ago

AES

Gilead price target raised to $96 from $70 at UBS

UBS raised the firm’s price target on Gilead (GILD) to $96 from $70 and keeps a Neutral rating...

2d ago

GILD

Gilead price target raised to $100 from $90 at Mizuho

Mizuho raised the firm’s price target on Gilead (GILD) to $100 from $90 and keeps an Outperform rating...

2d ago

GILD

Biogen price target lowered to $207 from $251 at Mizuho

Mizuho lowered the firm’s price target on Biogen (BIIB) to $207 from $251 and keeps an Outperform rating...

2d ago

BIIB

Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program

In a regulatory filing on Wednesday, Hookipa Pharma (HOOK) announced that on November 18, the company approved a...

2d ago

GILD

HOOK

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Biotech Stocks

AMGN

Amgen

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Assigned

2024-11-22

VRTX

Vertex Pharmaceuticals

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2024-11-22

IQV

IQVIA Holdings

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2024-11-21

MRNA

Moderna

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2024-11-21

GILD

Gilead Sciences

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2024-11-21

BIIB

Biogen

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2024-11-21

BNTX

BioNTech SE

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Upgraded

2024-11-19

ILMN

Illumina

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Assigned

2024-11-14

REGN

Regeneron

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Initiated

2024-11-14

VRTX

Vertex Pharmaceuticals

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2024-11-21

All Ratings >

Most Recent Earnings of Biotech Stocks

GILD

Gilead Sciences

Nov 06, 2024

Sep 01, 2024

1.53 / 2.02

1.72

AMGN

Amgen

Oct 30, 2024

Sep 01, 2024

5.27 / 5.58

4.71

VRTX

Vertex Pharmaceuticals

Nov 04, 2024

Sep 01, 2024

4.08 / 4.38

4.2

BIIB

Biogen

Oct 30, 2024

Sep 01, 2024

3.77 / 4.08

2.95

ILMN

Illumina

Nov 04, 2024

Sep 01, 2024

0.88 / 1.14

0.136

REGN

Regeneron

Oct 31, 2024

Sep 01, 2024

11.70 / 12.46

11.86

MRNA

Moderna

Nov 07, 2024

Sep 01, 2024

-1.80 / 0.03

0.55

IQV

IQVIA Holdings

Oct 31, 2024

Sep 01, 2024

2.82 / 2.84

2.84

BNTX

BioNTech SE

Nov 04, 2024

Sep 01, 2024

-1.61 / 0.85

1.9

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?

These Biotech stocks currently have a "Strong Buy" analyst rating consensus:

IQVIA Holdings - Strong Buy, based on 18 analyst ratings, 16 Buy, 2 Hold, and 0 Sell.

BioNTech SE - Strong Buy, based on 16 analyst ratings, 12 Buy, 4 Hold, and 0 Sell.

Are Biotech stocks overpriced?

Gilead Sciences's stock price is currently $90.19, and its average 12-month price target is $98.81.

Amgen's stock price is currently $294.53, and its average 12-month price target is $342.44.

Vertex Pharmaceuticals's stock price is currently $450.97, and its average 12-month price target is $514.68.

Biogen's stock price is currently $157.90, and its average 12-month price target is $247.59.

Illumina's stock price is currently $140.14, and its average 12-month price target is $164.35.

Regeneron's stock price is currently $738.00, and its average 12-month price target is $1,097.00.

Moderna's stock price is currently $41.11, and its average 12-month price target is $77.06.

IQVIA Holdings's stock price is currently $201.82, and its average 12-month price target is $254.56.

BioNTech SE's stock price is currently $113.13, and its average 12-month price target is $137.87.

Which Biotech stocks pay dividends?

Gilead Sciences currently pays a dividend of $0.77 which represents an annual dividend yield of 3.45%. Gilead Sciences's next Ex-dividend date is December 13, 2024 and its next payout date is December 30, 2024.

Amgen does not currently pay dividends.

Vertex Pharmaceuticals does not currently pay dividends.

Biogen does not currently pay dividends.

Illumina does not currently pay dividends.

Regeneron does not currently pay dividends.

Moderna does not currently pay dividends.

IQVIA Holdings does not currently pay dividends.

BioNTech SE does not currently pay dividends.